Nevro escalates patent dispute with Boston Scientific

Medical device maker Nevro has hit competitor Boston Scientific (BSC) with a lawsuit for allegedly infringing patents that cover a spinal cord stimulation technology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Boston Scientific loses stent patent case in uni feud

2 February 2023 Delaware jury finds that the infringement was intentional | Verdict comes in a long-running dispute that touched upon state sovereignty.

Medtech

Beckman Coulter loses late-stage bid to pause infringement proceedings

17 May 2022 The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded.

Medtech

Nevro claims BSC destroyed evidence in patent suit

26 October 2021 Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Nevro escalates patent dispute with Boston Scientific

More on this story

Editor's picks

Editor's picks

More features